Study to Evaluate the Safety of Repatha® in Pregnancy

TerminatedOBSERVATIONAL
Enrollment

4

Participants

Timeline

Start Date

January 12, 2017

Primary Completion Date

November 6, 2020

Study Completion Date

November 6, 2020

Conditions
HypercholesterolaemiaPregnancy
Trial Locations (48)

1211

Research Site, Geneva

2050

Research Site, Camperdown

2650

Research Site, Edegem

3000

Research Site, Leuven

3168

Research Site, Clayton

4000

Research Site, Liège

4153

Research Site, Reinach

7100

Research Site, La Louvière

8036

Research Site, Graz

8200

Research Site, Aarhus N

9300

Research Site, Aalst

11527

Research Site, Athens

14004

Research Site, Córdoba

16132

Research Site, Genova

18536

Research Site, Piraeus

20092

Research Site, Cinisello Balsamo (MI)

20122

Research Site, Milan

20162

Research Site, Milan

29010

Research Site, Málaga

41126

Research Site, Modena

43204

Research Site, Reus

44124

Research Site, Ferrara

45500

Research Site, Ioannina

50009

Research Site, Zaragoza

56100

Research Site, Pisa

71110

Research Site, Heraklion

80131

Research Site, Napoli

89125

Research Site, Messina

90127

Research Site, Palermo

500 05

Research Site, Hradec Králové

460 63

Research Site, Liberec

128 08

Research Site, Prague

686 01

Research Site, Uherské Hradiště

09134

Research Site, Cagliari

06129

Research Site, Perugia

00161

Research Site, Roma

1105 AZ

Research Site, Amsterdam

3015 CE

Research Site, Rotterdam

0586

Research Site, Oslo

831 01

Research Site, Bratislava

08907

Research Site, L'Hospitalet de Llobregat

205 02

Research Site, Malmo

751 85

Research Site, Uppsala

BH7 7DW

Research Site, Bournemouth

CB2 0QQ

Research Site, Cambridge

M13 9WL

Research Site, Manchester

PE3 9GZ

Research Site, Peterborough

SG1 4AB

Research Site, Stevenage

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY